Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaMoshe Sade-Feldman, Nir Hacohen, Keren Yizhak et al.|Cell|2018Cited by 2k
False-Positive Plasma Genotyping Due to Clonal HematopoiesisYuebi Hu, Geoffrey R. Oxnard, Cloud P. Paweletz et al.|Clinical Cancer Research|2018Cited by 445
Frameshift events predict anti–PD-1/L1 response in head and neck cancerGlenn J. Hanna, Robert I. Haddad, Patrick H. Lizotte et al.|JCI Insight|2018Cited by 279
Multiparametric profiling of non–small-cell lung cancers reveals distinct immunophenotypesPatrick H. Lizotte, Kwok‐Kin Wong|JCI Insight|2016Cited by 127
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancerGiacomo Oliveira, Ravindra Uppaluri, Ann Marie Egloff et al.|Science Immunology|2023Cited by 118